Methotrexate and mucositis: A merry-go-round for oncologists

Methotrexate and mucositis: A merry-go-round for oncologists

Blog Article

High-dose methotrexate is the backbone of various regimens DIL Switches for treating lymphoid malignancies.Mucositis is a well-known, dose-related side effect of methotrexate.Prophylactic measures such as folinic acid rescue are useful but do not prevent mucositis in all the cases.Once severe mucositis (WHO Grade IV) sets in, mortality is very high.The Universal Microswitch Kit index case highlights the natural course of methotrexate-induced mucositis and the need for swift and preemptive intervention.